Results 361 to 370 of about 22,658,854 (391)
Some of the next articles are maybe not open access.

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.

Journal of the National Cancer Institute, 1994
BACKGROUND Studies of human tumor-infiltrating lymphocytes (TILs) derived from patients with a variety of histologic types of cancer have demonstrated that cellular immune reactions against established malignancy exist in humans.
S. Rosenberg   +9 more
semanticscholar   +1 more source

[38] Human interleukin 2

1985
Publisher Summary This chapter describes certain approaches, which are most useful in the purification and characterization of human IL-2 and which have general applicability throughout the lymphokine field. Interleukin 2 (IL-2, T cell growth factor) is situated at the center of the cascade of antigen-nonspecific factors released during an immune ...
openaire   +3 more sources

Immunotherapy with Interleukin-2 [PDF]

open access: possible, 1989
Chemotherapy is capable of producing durable responses in only a few types of advanced cancer and there is therefore an urgent need for alternative approaches to treatment. For decades, immunologists have held the hope that it might be possible to induce or augment a host antitumour response and produce immune-mediated disease regression.
openaire   +1 more source

Interleukin 2: Biology and biochemistry

Journal of Clinical Immunology, 1983
Since its discovery as a T-cell growth factor, interleukin 2 (IL-2) has attracted considerable scientific attention, not only as a useful reagent for the maintenance of large numbers of effector T lymphocytes but as a potentially potent immunoregulatory molecule, which could be of therapeutic usefulness in a number of clinical conditions.
openaire   +2 more sources

Interleukin-2

The American Journal of Nursing, 1987
P F, Jassak, P L, Spiewak
openaire   +2 more sources

Interleukin-2

DMW - Deutsche Medizinische Wochenschrift, 2008
R, Fink, H, Dancygier
openaire   +2 more sources

Interleukin-2 Receptors

1985
Interleukin-2 (IL-2) is a lymphokine synthesized by some T-cells following activation. Resting T-cells do not express IL-2 receptors but receptors are rapidly expressed on T-cells following the interaction of antigens, mitogens, or monoclonal antibodies with the antigen specific T-cell receptor complex.
Kathleen F. Bongiovanni   +6 more
openaire   +2 more sources

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

Nature Network Boston, 2016
Jing He   +31 more
semanticscholar   +1 more source

Phase I Trial of Anti‐PSMA Designer CAR‐T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2‐T Cell Pharmacodynamics as a Determinant of Clinical Response

The Prostate, 2016
R. Junghans   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy